Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Pashayan

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2020
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population DataMinh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, et al.
Nature Communications|January 12, 2019
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
Research Square|April 10, 2023
Biochemical activity induced by a germline variation in <i>KLK3</i> (PSA) associates with cellular function and clinical outcome in prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.
Nature Communications|November 6, 2024
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.
Human Molecular Genetics|May 31, 2015
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among EuropeansAli Amin Al Olama, Tokhir Dadaev, Dennis J Hazelett, et al.
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 4, 2015
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility LociAli Amin Al Olama, Sara Benlloch, Antonis C Antoniou, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2018
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT StudyCharleen D Adams, Rebecca Richmond, Diana L Santos Ferreira, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2020
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population DataMinh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, et al.
Nature Communications|January 12, 2019
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
Research Square|April 10, 2023
Biochemical activity induced by a germline variation in <i>KLK3</i> (PSA) associates with cellular function and clinical outcome in prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.
Nature Communications|November 6, 2024
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.
Human Molecular Genetics|May 31, 2015
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among EuropeansAli Amin Al Olama, Tokhir Dadaev, Dennis J Hazelett, et al.
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 4, 2015
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility LociAli Amin Al Olama, Sara Benlloch, Antonis C Antoniou, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2018
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT StudyCharleen D Adams, Rebecca Richmond, Diana L Santos Ferreira, et al.
Pageof 18